The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Finasteride Oral Tablet Market Research Report 2025
Synopsis
Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Global Finasteride Oral Tablet market is projected to reach US$ 1283.9 million in 2029, increasing from US$ 672.9 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Oral Tablet market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Finasteride Oral Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Finasteride Oral Tablet report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Global Finasteride Oral Tablet market is projected to reach US$ 1283.9 million in 2029, increasing from US$ 672.9 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Finasteride Oral Tablet market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Finasteride Oral Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Finasteride Oral Tablet report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Finasteride Oral Tablet Market Overview
1.1 Product Overview and Scope of Finasteride Oral Tablet
1.2 Finasteride Oral Tablet Segment by Type
1.2.1 Global Finasteride Oral Tablet Market Value Comparison by Type (2023-2029)
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Finasteride Oral Tablet Segment by Application
1.3.1 Global Finasteride Oral Tablet Market Value by Application: (2023-2029)
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Global Finasteride Oral Tablet Market Size Estimates and Forecasts
1.4.1 Global Finasteride Oral Tablet Revenue 2018-2029
1.4.2 Global Finasteride Oral Tablet Sales 2018-2029
1.4.3 Global Finasteride Oral Tablet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Finasteride Oral Tablet Market Competition by Manufacturers
2.1 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Finasteride Oral Tablet Average Price by Manufacturers (2018-2023)
2.4 Global Finasteride Oral Tablet Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Finasteride Oral Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Finasteride Oral Tablet, Product Type & Application
2.7 Finasteride Oral Tablet Market Competitive Situation and Trends
2.7.1 Finasteride Oral Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Finasteride Oral Tablet Players Market Share by Revenue
2.7.3 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Finasteride Oral Tablet Retrospective Market Scenario by Region
3.1 Global Finasteride Oral Tablet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Finasteride Oral Tablet Global Finasteride Oral Tablet Sales by Region: 2018-2029
3.2.1 Global Finasteride Oral Tablet Sales by Region: 2018-2023
3.2.2 Global Finasteride Oral Tablet Sales by Region: 2024-2029
3.3 Global Finasteride Oral Tablet Global Finasteride Oral Tablet Revenue by Region: 2018-2029
3.3.1 Global Finasteride Oral Tablet Revenue by Region: 2018-2023
3.3.2 Global Finasteride Oral Tablet Revenue by Region: 2024-2029
3.4 North America Finasteride Oral Tablet Market Facts & Figures by Country
3.4.1 North America Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Finasteride Oral Tablet Sales by Country (2018-2029)
3.4.3 North America Finasteride Oral Tablet Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Finasteride Oral Tablet Market Facts & Figures by Country
3.5.1 Europe Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Finasteride Oral Tablet Sales by Country (2018-2029)
3.5.3 Europe Finasteride Oral Tablet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Oral Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Finasteride Oral Tablet Sales by Country (2018-2029)
3.6.3 Asia Pacific Finasteride Oral Tablet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Finasteride Oral Tablet Market Facts & Figures by Country
3.7.1 Latin America Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Finasteride Oral Tablet Sales by Country (2018-2029)
3.7.3 Latin America Finasteride Oral Tablet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Finasteride Oral Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Oral Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Finasteride Oral Tablet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Finasteride Oral Tablet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Finasteride Oral Tablet Sales by Type (2018-2029)
4.1.1 Global Finasteride Oral Tablet Sales by Type (2018-2023)
4.1.2 Global Finasteride Oral Tablet Sales by Type (2024-2029)
4.1.3 Global Finasteride Oral Tablet Sales Market Share by Type (2018-2029)
4.2 Global Finasteride Oral Tablet Revenue by Type (2018-2029)
4.2.1 Global Finasteride Oral Tablet Revenue by Type (2018-2023)
4.2.2 Global Finasteride Oral Tablet Revenue by Type (2024-2029)
4.2.3 Global Finasteride Oral Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Finasteride Oral Tablet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Finasteride Oral Tablet Sales by Application (2018-2029)
5.1.1 Global Finasteride Oral Tablet Sales by Application (2018-2023)
5.1.2 Global Finasteride Oral Tablet Sales by Application (2024-2029)
5.1.3 Global Finasteride Oral Tablet Sales Market Share by Application (2018-2029)
5.2 Global Finasteride Oral Tablet Revenue by Application (2018-2029)
5.2.1 Global Finasteride Oral Tablet Revenue by Application (2018-2023)
5.2.2 Global Finasteride Oral Tablet Revenue by Application (2024-2029)
5.2.3 Global Finasteride Oral Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Finasteride Oral Tablet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Finasteride Oral Tablet Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Accord Healthcare UK
6.2.1 Accord Healthcare UK Corporation Information
6.2.2 Accord Healthcare UK Description and Business Overview
6.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Portfolio
6.2.5 Accord Healthcare UK Recent Developments/Updates
6.3 Relonchem
6.3.1 Relonchem Corporation Information
6.3.2 Relonchem Description and Business Overview
6.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Relonchem Finasteride Oral Tablet Product Portfolio
6.3.5 Relonchem Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sandoz Finasteride Oral Tablet Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Teva Generics
6.5.1 Teva Generics Corporation Information
6.5.2 Teva Generics Description and Business Overview
6.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Generics Finasteride Oral Tablet Product Portfolio
6.5.5 Teva Generics Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cipla Finasteride Oral Tablet Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Dr. Reddy
6.6.1 Dr. Reddy Corporation Information
6.6.2 Dr. Reddy Description and Business Overview
6.6.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy Finasteride Oral Tablet Product Portfolio
6.7.5 Dr. Reddy Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 Henan Topfond
6.9.1 Henan Topfond Corporation Information
6.9.2 Henan Topfond Description and Business Overview
6.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Henan Topfond Finasteride Oral Tablet Product Portfolio
6.9.5 Henan Topfond Recent Developments/Updates
6.10 Zhejiang CONBA Pharmaceutical
6.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
6.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
6.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Portfolio
6.10.5 Zhejiang CONBA Pharmaceutical Recent Developments/Updates
6.11 Shandong Renhetang Pharmaceutical
6.11.1 Shandong Renhetang Pharmaceutical Corporation Information
6.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Description and Business Overview
6.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Portfolio
6.11.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.12 Guangdong Eashu Pharmacetical
6.12.1 Guangdong Eashu Pharmacetical Corporation Information
6.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Description and Business Overview
6.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Portfolio
6.12.5 Guangdong Eashu Pharmacetical Recent Developments/Updates
6.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
6.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
6.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Description and Business Overview
6.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Portfolio
6.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Oral Tablet Industry Chain Analysis
7.2 Finasteride Oral Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Oral Tablet Production Mode & Process
7.4 Finasteride Oral Tablet Sales and Marketing
7.4.1 Finasteride Oral Tablet Sales Channels
7.4.2 Finasteride Oral Tablet Distributors
7.5 Finasteride Oral Tablet Customers
8 Finasteride Oral Tablet Market Dynamics
8.1 Finasteride Oral Tablet Industry Trends
8.2 Finasteride Oral Tablet Market Drivers
8.3 Finasteride Oral Tablet Market Challenges
8.4 Finasteride Oral Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
